1.

患者基线特征

Baseline demographic and disease characteristics

Characteristics	Recombinant human endostatin+chemotherapy (n=15)
ECOG: Eastern Cooperative Oncology Group; PS: performance score; CNS: central nervous system.
Age in years, median (range)	59 (40-71)
Male/female, n (%)	14 (93.3)/1 (6.7)
ECOG PS 0/1, n (%)	8 (53.3)/7 (46.7)
Smoking/non-smoking, n (%)	10 (66.7)/5 (33.3)
Metastatic sites, n (%)   Mediastinal lymph nodes/lung/bone/renal/liver/CNS/other lymph nodes	10 (66.7)/5 (40.0)/5 (33.3)/3 (20.0)/2 (13.3)/1 (6.7)/1 (6.7)/2 (13.3)
Chemotherapy agents, n (%)   Gemcitabine   Docetaxel   Paclitaxel   Cisplatin   Other	8（53.3） 3（20.0） 3（20.0） 14（93.3） 1（6.7）